SciDev Ltd (SDV) AI Stock Analysis

• Market Cap: AU$73.18M
• Dividend Yield: N/A
• Average Volume (3M): 156.16K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.07
• Revenue Growth: -5.37%
• EPS Growth: -140.00%
• Country: AU
• Employees: 22
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): >-0.01
• Shares Outstanding: 190,088,580
• 10 Day Avg. Volume: 144,930
• 30 Day Avg. Volume: 156,164
• PEG Ratio: 0.51
• Price to Book (P/B): 1.26
• Price to Sales (P/S): 0.61
• P/FCF Ratio: 80.53
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 53 Neutral
• Price Target: AU$0.39 ▼(-15.00% Downside)

SciDev Ltd's stock score is primarily influenced by its mixed financial performance, with stable cost management but challenges in profitability and cash flow. The technical analysis indicates positive momentum, which is a significant strength. However, the valuation is concerning due to a negative P/E ratio, highlighting potential financial distress.

Positive Factors

Business Model Strength

SciDev's diversified revenue streams from product sales, software subscriptions, and consultancy services provide a robust business model that supports long-term growth and market resilience.

Strategic Partnerships

Partnerships and collaborations enhance SciDev's market reach and product offerings, positioning the company well for sustained growth and innovation in the scientific solutions sector.

Balance Sheet Health

SciDev's low leverage provides financial stability and flexibility, allowing the company to invest in growth opportunities without significant debt-related constraints.

Negative Factors

Revenue Growth Challenges

Inconsistent revenue growth and negative profit margins highlight difficulties in scaling operations and achieving profitability, potentially limiting long-term financial performance.

Cash Flow Decline

Declining free cash flow suggests potential liquidity constraints, which could impact SciDev's ability to fund operations and invest in future growth initiatives.

Profitability Challenges

Negative net profit margins indicate ongoing struggles with profitability, which may hinder SciDev's capacity to generate shareholder value and reinvest in the business.

SciDev Ltd Business Overview & Revenue Model

Company Description

SciDev Limited engages in supply of process control, professional services, equipment design and construction, and chemistry in Australia and the United States. The company offers coagulants and flocculants in powder and liquid form under the MaxiFlox and MaxiDry name; engineering and process control; chemistry products for applications, including thickening, filtration, centrifuging, friction reduction, shale inhibition, rheology control, and carrier fluids; chemical batching, storage, and dosage systems; engineering solutions and technologies under the TrueMud and OptiFlox name; friction reducers under the DrySlik, WetSlik, and CarrySlik names; and dynamic shears. It serves water and wastewater treatment, mining and minerals processing, oil and gas, construction, food processing, dairy, power generation, personal products and cosmetics manufacturing, paper and cardboard manufacturing, and paint manufacturing industries. The company was formerly known as Intec Limited and changed its name to SciDev Limited in March 2017. SciDev Limited was incorporated in 1973 and is headquartered in Kings Park, Australia.

How the Company Makes Money

SciDev Ltd generates revenue primarily through the sale of its proprietary scientific instruments and software solutions, which are utilized by research institutions and commercial laboratories. Additionally, the company earns income from providing consultancy services, training programs, and technical support related to its products. Key revenue streams include direct product sales, subscription fees for software services, and project-based contracts with academic and industry partners. Strategic partnerships with leading research organizations and collaborations with other technology firms further bolster its earnings by expanding its market reach and enhancing product offerings.

SciDev Ltd Financial Statement Overview

Summary

SciDev Ltd faces challenges in achieving consistent revenue growth and profitability, with negative net profit margins and declining free cash flow. The balance sheet is stable with low leverage, but the company struggles to generate returns on equity. Strengths in cost management are offset by weaknesses in profitability and cash flow generation.

Income Statement

SciDev Ltd has shown fluctuating revenue growth with a recent decline of 4.96%. The gross profit margin is relatively stable at 32.26%, indicating efficient cost management. However, the net profit margin is negative at -0.85%, reflecting challenges in achieving profitability. EBIT and EBITDA margins are modest, suggesting limited operational efficiency improvements.

Balance Sheet

The company maintains a low debt-to-equity ratio of 0.13, indicating conservative leverage. However, the return on equity is negative at -1.75%, highlighting challenges in generating returns for shareholders. The equity ratio is not explicitly provided, but the low debt levels suggest a stable financial structure.

Cash Flow

Free cash flow growth has significantly declined by 88.63%, indicating potential liquidity issues. The operating cash flow to net income ratio is low at 0.13, suggesting limited cash generation relative to earnings. The free cash flow to net income ratio is 0.27, reflecting challenges in converting earnings into cash flow.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	103.50M	103.50M	109.09M	89.72M	55.60M	42.52M
Gross Profit	33.39M	33.39M	33.97M	6.83M	3.69M	1.37M
EBITDA	5.91M	5.91M	7.65M	4.11M	1.13M	1.88M
Net Income	-878.00K	-878.00K	2.17M	-339.00K	-616.00K	3.45M
Balance Sheet
Total Assets	75.23M	75.23M	72.01M	67.37M	71.16M	56.15M
Cash, Cash Equivalents and Short-Term Investments	9.68M	9.68M	9.43M	7.73M	14.06M	7.01M
Total Debt	6.26M	6.26M	5.13M	3.48M	2.90M	5.13M
Total Liabilities	25.18M	25.18M	21.78M	19.35M	22.32M	24.54M
Stockholders Equity	50.05M	50.05M	50.24M	48.02M	48.84M	31.61M
Cash Flow
Free Cash Flow	785.00K	785.00K	4.48M	522.00K	-3.83M	-1.92M
Operating Cash Flow	2.87M	2.87M	6.48M	4.81M	-1.31M	-1.32M
Investing Cash Flow	-2.35M	-2.35M	-3.71M	-8.39M	-6.65M	-2.49M
Financing Cash Flow	-390.00K	-390.00K	-1.06M	-2.83M	14.99M	6.34M

SciDev Ltd Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.46
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:SDV, the sentiment is Negative. The current price of 0.46 is above the 20-day moving average (MA) of 0.44, above the 50-day MA of 0.44, and above the 200-day MA of 0.36, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 34.04 is Neutral, neither overbought nor oversold. The STOCH value of 11.40 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:SDV.

SciDev Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
CXL	55 Neutral	AU$273.78M	-12.92	-22.28%	―	16.47%	29.53%
CG1	55 Neutral	AU$39.00M	-4.97	-67.76%	―	7.08%	33.70%
SPN	54 Neutral	AU$25.41M	-9.31	-63.81%	―	―	52.66%
SDV	53 Neutral	AU$73.18M	-83.70	-1.75%	―	-5.37%	-140.00%
DTZ	41 Neutral	AU$27.72M	-2.76	-869.14%	―	340.27%	19.44%
AJX	37 Underperform	AU$18.77M	-2.78	-263.52%	―	-32.85%	28.00%

SciDev Ltd Corporate Events

SciDev Ltd Director Acquires Additional Shares

SciDev Ltd has announced a change in the director’s interest, with Johannes Risseeuw acquiring 70,000 fully paid ordinary shares through an on-market purchase at an average price of $0.43 per share. This acquisition reflects a strategic move by the director, potentially indicating confidence in the company’s future performance and stability, which may influence stakeholder perceptions and market positioning.

The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.

SciDev Ltd Director Increases Shareholding with Significant Acquisition

SciDev Ltd has announced a change in the director’s interest, with Director Mike Utsler acquiring 55,000 fully paid ordinary shares through an on-market purchase at an average price of $0.44 per share. This acquisition increases his total shareholding to 117,111 shares, reflecting a significant personal investment in the company, which could indicate confidence in SciDev’s future performance and strategic direction.

The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.

SciDev Ltd 2025 AGM: Key Resolutions Passed, Strategic Capacity Expansion Rejected

SciDev Ltd announced the results of its 2025 Annual General Meeting, where three out of four resolutions were passed, including the re-election of Mr. Jon Gourlay and the election of Mr. Johannes Risseeuw as Directors. However, the resolution for an additional 10% placement capacity was not approved. This outcome may influence the company’s strategic decisions and shareholder relations moving forward.

The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.

SciDev Ltd Reports Resilient FY25 Performance Amid Market Challenges

In its 2025 AGM, SciDev Ltd reported a stable financial performance for FY25, with revenues of A$103.4 million and an underlying EBITDA of A$7.1 million, despite market volatility. The company achieved significant progress in its strategic objectives, particularly in its Energy Services segment, which saw increased sales and market share, notably re-entering the Permian Basin with a $10 million supply agreement. The Process Chemistry segment overcame challenges in the mining sector by securing new business in mineral sands and construction, while the Water Technologies segment expanded its global footprint and secured a $19.5 million contract for a groundwater treatment plant. These developments underscore SciDev’s strategic investments and market positioning, enhancing its growth prospects and stakeholder value.

The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.

SciDev Ltd Strengthens Strategic Focus Amidst Environmental Challenges

SciDev Ltd has strategically positioned itself to address significant environmental challenges, focusing on PFAS remediation, industrial water treatment, and energy sector water management. The company has strengthened its foundation in FY25 by improving its operating rhythm and defining a sharper strategic focus, ensuring it remains at the forefront of emerging environmental investment cycles. The Board emphasizes governance priorities such as capital discipline and aligning investments with proven opportunities to build a sustainable and reliable company.

The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.

SciDev Secures $19.5 Million Contract for Rum Jungle Rehabilitation

SciDev Ltd has secured a $19.5 million contract for the design and construction of a groundwater treatment plant as part of the Rum Jungle Rehabilitation Project in Australia. This project, a significant environmental remediation effort, aims to treat contaminated groundwater from legacy uranium mining, benefiting the local community and environment. The contract underscores SciDev’s capability in delivering specialized water treatment solutions and enhances its position in the market for large-scale mine rehabilitation.

The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.